Cite
HARVARD Citation
Foureau, D. et al. (2020). Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma. EJHaem. 1 (1), pp. 113-121. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Foureau, D. et al. (2020). Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma. EJHaem. 1 (1), pp. 113-121. [Online].